ChemChina Business Profile and Key Facts Revealed

ChemChina is a Chinese state-owned conglomerate that has made significant strides in the global chemical industry. It was founded in 2008 through the merger of China National Chemical Corporation and China National Bluestar Company.

ChemChina is headquartered in Beijing, China, and operates in over 100 countries worldwide. Its global presence is a testament to its ambitious expansion plans.

ChemChina's business profile is characterized by its diverse portfolio of chemicals, fertilizers, and other related products. Its products cater to various industries, including agriculture, construction, and manufacturing.

ChemChina's revenue has consistently grown over the years, with the company reporting a significant increase in sales in 2020.

For more insights, see: Chemchina Syngenta

ChemChina was formed in May 2004 after the State Council of the People's Republic of China approved a merger of companies formerly under the Ministry of Chemical Industry. This marked the beginning of the company's journey as a state-owned entity.

Ren Jianxin became the CEO of ChemChina in May 2004 and later took on the role of chairman of the board of directors in December 2014. He played a crucial part in shaping the company's future.

Additional reading: Gangmasters (Licensing) Act 2004

ChemChina's agrochemicals business has a large portfolio of companies, including Sanonda Holdings and Makhteshim Agan, which it acquired in 2011 for 2.4 billion US dollars. This acquisition made ChemChina the largest manufacturer of generic pesticides.

The company made significant overseas acquisitions, including the Adisseo Group and the organic silicon and sulphide business of Rhodia. These deals helped ChemChina become the third-largest producer in the world of organic silicon.

ChemChina's petrochemical processing division operates refineries, including small ones known as teapot plants, giving it an oil processing capacity of about 25 million tonnes a year. This is a significant achievement for the company.

ChemChina has expanded its operations globally, opening a trading office in Singapore in October 2013. This move was a strategic step in the company's expansion plans.

Here are some key milestones in ChemChina's history:

In 2016, ChemChina agreed to a $43 billion bid for Syngenta, the largest ever foreign purchase by a Chinese firm.

This deal was awaiting approval by the Committee on Foreign Investment in the United States (CFIUS) and European government panels, citing food safety and security concerns.

The Australian Competition & Consumer Commission cleared the deal in December 2016, but it was again delayed due to European antitrust investigations.

ChemChina was required to divest from pesticide production of paraquat, abamectin, and chlorothalonil as part of the deal.

The European Commission also addressed competition concerns with regard to plant growth regulators and reiterated the expected commitments for divestment from ADAMA-related products.

By May 2017, ChemChina's plan to purchase Syngenta for $44 billion was nearing completion, with ChemChina amassing "huge bridge loans" to pay Syngenta stockholders.

The deal was completed that same month with 82.2 percent of Syngenta shares and depository receipts offered.

In 2021, ChemChina merged with state-owned Sinochem to form Sinochem Holdings Corporation Ltd.

The Chinese government approved the merger, stating that the companies will undergo a joint restructuring and become subsidiaries of a new and yet-to-be-named holding company.

A timetable for the restructuring has not been disclosed.

If this caught your attention, see: Sinochem Group

ChemChina's regulatory challenges began with its acquisition of Pirelli in 2015, which faced opposition from the Italian government due to concerns over job losses and foreign ownership.

The company's financial struggles were also evident, with a reported €2.8 billion debt at the time of the acquisition.

ChemChina's acquisition of Pirelli was valued at €7.1 billion, making it one of the largest foreign investments in Italy at the time.

ChemChina's financial situation was further complicated by the fact that it had to pay a €1.3 billion breakup fee to Pirelli's shareholders if the deal fell through.

The acquisition was eventually approved, but not before ChemChina agreed to certain conditions, including the creation of 2,000 new jobs in Italy.

ChemChina's financial struggles continued to impact the company, with a reported €3.6 billion loss in 2016, largely due to the acquisition of Pirelli.

Explore further: The Importer Reported a Generic Error

ChemChina has a diverse range of subsidiaries, each contributing to the company's overall growth and success.

Sinochem, a key subsidiary, was established in 1950 and has since become a leading player in the Chinese chemical industry.

ChemChina's acquisition of Pirelli in 2015 was a significant move, expanding the company's presence in the global tire market.

Sinochem's subsidiaries include China National Chemical Corporation, which is responsible for managing the company's chemical assets.

ChemChina has also invested in Sinopec, a leading Chinese energy and chemical company, further expanding its reach in the industry.

The acquisition of Pirelli's assets in 2016 marked a major milestone for ChemChina, solidifying its position in the global tire market.

ChemChina's subsidiaries operate in various sectors, including chemicals, energy, and agriculture, showcasing the company's diversified business portfolio.

On a similar theme: Goodyear Tire and Rubber Company